Rasagiline Tablet
Product Images NDC 64980-712

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 64980-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.5mg-imprint-code (Code 0.5 mg)

FDA Label Image

1mg-imprint-code (Code 1 mg)

FDA Label Image

0.5 mg-30 Tablets Bottle Label (Rasagiline 0.5mg 30ct Label)

This text provides details about a medication in tablet form containing 0.5 mg of rasagiline distributed by Rising Pharma Holdings, Inc. Each tablet is equivalent to 0.78 mg of rasagiline mesylate. It includes information on dosage, storage conditions (20°C to 25°C), expiration date (06/2025), and packaging is child-resistant. The medication is made in India.*

FDA Label Image

Rasagiline-1mg-30ct-label (Rasagiline 1mg 30ct Label)

This is a description of a medication package containing tablets of rasagiline, each tablet containing 1 mg of rasagiline mesylate. The usual dosage information is provided, and the tablets are manufactured in India and distributed by Rising Pharma Holdings, Inc. The package is child-resistant and should be stored at room temperature. The text also includes prescribing information and details for dispensing the tablets.*

FDA Label Image

Rasagiline-structure.jpg (Rasagiline Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.